ELVN Financials
Enliven Therapeutics Inc. - Financial statements & key metrics
Stock Price
$58.98
Market Cap
$2.11B
P/E Ratio
-31.2
EPS
$-1.89
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-89.02M
EPS (Diluted)
$-1.89
Balance Sheet Highlights
Total Assets
$325.76M
Total Liabilities
$15.91M
Shareholders Equity
-
Cash & Equivalents
$124.12M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-73.19M
CapEx
-
Free Cash Flow
-
Profitability Metrics
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ELVN revenue?
View ELVN's income statement for detailed revenue data.
Is ELVN profitable?
ELVN reported a loss of $89.02M in the most recent quarter.
What is ELVN market cap?
ELVN has a market capitalization of $2.11B, making it a mid-cap stock.
Does ELVN have debt?
View ELVN's balance sheet for debt information.
What is ELVN cash flow?
Cash flow data is available in the full financial statements.